glp 1 documentary Before GLP-1 meds we had lifestyle and some OKAY medicines and then su... | medicine Life After GLP-1: The Evidence-Based
Description
Whats different in 2024 is that we are seeing the birth of a major new market for effective prescription medications which promise unprecedented impact not just on obesity, but on the health issues associated with obesity
Low FODMAP
The World Health Organization is backing GLP-1 medications for the treatment of obesity, which some advocates hope will open up access to the drugs and improve affordability
Furthermore, attention is given to individualized treatment approaches for special populations, as well as to emerging therapeutic avenues such as nanotechnology and extracellular vesicle-based interventions
Find out if Novo's GLP-1 patent expiring in Canada is a mistake or a calculated move
Drug exposure is largely independent of injection site, as well as age, race and ethnicity
